ARCA biopharma, Inc.·4

Apr 3, 5:00 PM ET

Selby Brian L. 4

4 · ARCA biopharma, Inc. · Filed Apr 3, 2018

Insider Transaction Report

Form 4
Period: 2018-04-02
Selby Brian L.
VP, Finance
Transactions
  • Sale

    Common Stock

    2018-04-02$0.50/sh1,114$5560 total
Footnotes (1)
  • [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan").

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION